Vascularized allogeneic joint, muscle, and peripheral nerve transplantation

Area of Science:

• Immunology
• Transplantation Biology
• Regenerative Medicine

Background:

• Vascularized allotransplantation of musculoskeletal tissues presents significant immunological challenges.
• Short-term immunosuppression is often insufficient to prevent graft rejection in complex tissue transplants.
• Establishing long-term graft survival and function is critical for clinical success.

Purpose of the Study:

• To evaluate the efficacy of short-term cyclosporine immunosuppression in preventing rejection of vascularized joint, muscle, and peripheral nerve allografts.
• To determine if immunotolerance could be induced following a limited period of immunosuppression.
• To assess the long-term outcomes of allotransplantation with and without sustained immunosuppression.

Main Methods:

• Vascularized orthotopic allotransplantation of knee joints, rectus femoris muscles, and great saphenous nerves across a major histocompatibility complex barrier in inbred rats.
• Administration of cyclosporine for 4 to 6 weeks postoperatively, followed by drug withdrawal.
• Control groups included long-term cyclosporine administration and nonvascularized transplantation.
• Graft assessment until Week 12, including rejection monitoring and functional evaluation.

Main Results:

• Graft rejection was delayed by 2-3 weeks after cyclosporine withdrawal, but all allografts were eventually rejected.
• Immunotolerance was not achieved with short-term immunosuppression.
• Joint allografts initially achieved bony union but were later destroyed by pathologic fractures.
• Long-term cyclosporine treatment prevented rejection and improved function, but high doses led to mortality.
• Nonvascularized grafts showed poor outcomes, confirming the necessity of vascularization.

Conclusions:

• Short-term cyclosporine immunosuppression is inadequate for inducing long-term acceptance of vascularized joint, muscle, and nerve allografts.
• Sustained immunosuppression is required to prevent rejection, though it carries risks of toxicity.
• Graft vascularization is essential for successful skeletal tissue allotransplantation.
• Further research is needed to develop strategies for inducing stable immunotolerance in allotransplantation.